Status:
COMPLETED
Perinatal Outcomes and Hematologic Parameters in COVID-19 Pregnancies
Lead Sponsor:
Ankara City Hospital Bilkent
Conditions:
Pregnancy, Infections in
Covid19
Eligibility:
FEMALE
18-42 years
Brief Summary
Complete blood count parameters are routinely evaluated cost-effective markers in diagnosis and clinical follow-up of infectious diseases.There is increasing number of studies to report the course of ...
Detailed Description
The objective of this study is to evaluate the relationship between Coronavirus Disease 2019 (COVID-19) in pregnancy and adverse perinatal outcomes. The secondary aim is to analyze the diagnostic valu...
Eligibility Criteria
Inclusion
- Spontaneous pregnancy,
- Singleton pregnancy,
- Clinically diagnosed COVID-19 (SARS-CoV-2 positivity in real time-polymerase chain reaction)
Exclusion
- Chronic maternal diseases (rheumatological diseases, renal failure, vascular malformations, hypertension, cardiac disease, diabetes mellitus, obesity, hypo-hyperthyroidism, congenital hematological disorders),
- Acute inflammatory conditions (acute pancreatitis, acute appendicitis),
- Pregnancy complications (gestational diabetes, PPROM, preeclampsia),
- Multiple pregnancies,
- Anticoagulant medication.
Key Trial Info
Start Date :
March 10 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 10 2020
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT04515108
Start Date
March 10 2020
End Date
August 10 2020
Last Update
August 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ankara City Hospital
Ankara, Turkey (Türkiye), 06100